Schedule 13D ownership disclosure

EIGER BIOPHARMACEUTICALS INC

Security class unavailable · CUSIP: 28249U105

Event date: 2019-01-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-19-020636
Form type
SC 13D/A
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
Jan 29, 2019
Reporting period
Jan 25, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub